Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.
Erythropoietin Stimulating Agents Market contains market size and forecasts of Erythropoietin Stimulating Agents in Global, including the following market information:
- Global Erythropoietin Stimulating Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Erythropoietin Stimulating Agents market was valued at 6111 million in 2021 and is projected to reach US$ 6663.4 million by 2028, at a CAGR of 1.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epoetin Alfa Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erythropoietin Stimulating Agents include Pfizer, Amgen, BioSidus, Biocon, Celltrion, Roche, Intas Pharmaceuticals, Johnson and Johnson and Teva Pharmaceutical Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Erythropoietin Stimulating Agents companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erythropoietin Stimulating Agents Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Erythropoietin Stimulating Agents Market Segment Percentages, by Type, 2021 (%)
- Epoetin Alfa
- Epoetin Beta
- Darbepoetin Alfa
- Others
Global Erythropoietin Stimulating Agents Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Erythropoietin Stimulating Agents Market Segment Percentages, by Application, 2021 (%)
Global Erythropoietin Stimulating Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Erythropoietin Stimulating Agents Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Erythropoietin Stimulating Agents revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Erythropoietin Stimulating Agents revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Amgen
- BioSidus
- Biocon
- Celltrion
- Roche
- Intas Pharmaceuticals
- Johnson and Johnson
- Teva Pharmaceutical Industries
- Thermo Fisher Scientific
Industry Market Size
